Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01227889
Brief Title: A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma

First Submitted : October 21, 2010
First Submitted that Met QC Criteria : October 21, 2010
First Posted : October 25, 2010 (Estimate)

Results First Submitted : June 6, 2013
Results First Submitted that Met QC Criteria : April 17, 2014
Results First Posted : May 16, 2014 (Estimate)

Certification/Extension First Submitted : January 4, 2013
Certification/Extension First Submitted that Met QC Criteria : January 4, 2013
Certification/Extension First Posted : January 10, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : September 6, 2017
Last Update Posted : October 4, 2017